Related Experiment Video
Updated: May 20, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Cardiac involvement in Anderson-Fabry disease
Filippo Maria Cauti1, Constantinos O'Mahony, Antonis Pantazis
1Cardiology Department, University of Rome Sapienza, Rome, Italy. filippocauti@hotmail.it
Insights
Anderson-Fabry disease (AFD) can cause cardiac symptoms like left ventricular hypertrophy. Early diagnosis and treatment with recombinant enzyme are crucial, even though complications like arrhythmias may occur.
Area of Science:
- Cardiology
- Genetics
- Metabolic Disorders
Background:
- Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disorder.
- It results from mutations in the GLA gene, leading to deficient alpha-galactosidase A activity.
- Cardiac involvement, including left ventricular hypertrophy (LVH), is a significant manifestation.
Observation:
- A 50-year-old normotensive male presented with cardiac symptoms attributed to LVH.
- His condition was diagnosed as AFD, stemming from a GLA gene mutation.
- The patient experienced arrhythmias during recombinant enzyme replacement therapy, necessitating an implantable cardioverter-defibrillator.
Findings:
- Cardiac symptoms in this patient were directly linked to Anderson-Fabry disease.
- Recombinant enzyme therapy, while initiated, did not prevent complications such as arrhythmias.
- The case highlights the complex clinical course of AFD, even with treatment.
Implications:
- This case underscores the importance of considering AFD in patients with unexplained LVH and cardiac symptoms.
- Availability of effective treatments for AFD emphasizes the need for timely diagnosis.
- Early recognition facilitates screening of at-risk family members, potentially preventing severe complications.
Abstract:
A normotensive 50-year-old man was evaluated for cardiac symptoms associated with left ventricular hypertrophy (LFH). His symptoms were caused by cardiac involvement from Anderson-Fabry disease (AFD), an X linked lysosomal storage disease caused by mutations in the GLA gene which encodes for the lysosomal enzyme -galactosidase A. He was treated with recombinant enzyme but the clinical course was complicated by arrhythmias and the patient required an internal cardioverter defibrillator. Even though AFD is rare, this case illustrates the importance of considering the diagnosis in selected patients as effective treatment has recently become available. Recognition of AFD also allows for screening of asymptomatic relatives who may benefit from treatment before irreversible life-threatening complications develop.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction
